Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
12.85
+0.12 (0.94%)
Nov 21, 2024, 4:00 PM EST - Market closed
Pliant Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$40.50
Upside
+215.18%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +195.72% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +195.72% | Sep 13, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $33 | Buy | Initiates | $33 | +156.81% | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $38 | Strong Buy | Maintains | $36 → $38 | +195.72% | Aug 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $48 → $45 | Buy | Maintains | $48 → $45 | +250.19% | Aug 8, 2024 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +195.72% | Aug 8, 2024 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +195.72% | Jul 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +180.16% | Jul 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +180.16% | Jun 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +180.16% | May 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +195.72% | May 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +180.16% | May 7, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $45 → $44 | Strong Buy | Maintains | $45 → $44 | +242.41% | May 7, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $54 → $45 | Buy | Maintains | $54 → $45 | +250.19% | May 7, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $47 → $48 | Buy | Reiterates | $47 → $48 | +273.54% | May 7, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.